Picture of Dermapharm Holding SE logo

DMP — Dermapharm Holding SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Dermapharm H1 Adjusted Group EBITDA Margin At 28.9%

Aug 16 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * BOARD OF MANAGEMENT CONFIRMS OUTLOOK FOR FULL YEAR 2023
    * ADJUSTED GROUP EBITDA MARGIN AT A PLEASING 28.9%

Source text for Eikon:  ID:nEQ6rvzPNa 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Dermapharm Holding SE

See all news